CBL Chromosome 11
Cbl proto-oncogene
Upload your DNA to see your personal genotypes for variants in CBL.
What This Gene Does
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Jul 2016]
Gene Info
Gene Group
Ring finger proteins
Locus Type
gene with protein product
Location
11q23.3
Ensembl
ENSG00000110395
Associated Conditions (26)
RASopathy
CBL-related disorder
Juvenile myelomonocytic leukemia
Cardiovascular phenotype
Noonan syndrome and Noonan-related syndrome
Central nervous system germ cell tumor
Hereditary cancer-predisposing syndrome
Rhabdomyosarcoma
Myeloproliferative disorder
Growth failure in early childhood
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia
Intellectual disability
Noonan syndrome
Inborn genetic diseases
See cases
Hepatosplenomegaly
Epilepsy
early-onset
Pilocytic astrocytoma
Malignant germ cell tumor of ovary
+6 more conditions
Key Variants
RS1060500676
Conflicting classifications of pathogenicity
RASopathy, CBL-related disorder, RASopathy
Health Risk
RS112330156
Conflicting classifications of pathogenicity
RASopathy, CBL-related disorder, Juvenile myelomonocytic leukemia
Health Risk
RS1188095865
Conflicting classifications of pathogenicity
RASopathy, Cardiovascular phenotype, CBL-related disorder
Health Risk
RS1188757026
Conflicting classifications of pathogenicity
Cardiovascular phenotype, RASopathy, Cardiovascular phenotype
Health Risk
RS1193552867
Conflicting classifications of pathogenicity
Noonan syndrome and Noonan-related syndrome, RASopathy, Cardiovascular phenotype
Health Risk
RS1214485253
Conflicting classifications of pathogenicity
RASopathy, Cardiovascular phenotype, RASopathy
Health Risk
RS1229733932
Conflicting classifications of pathogenicity
Health Risk
RS1299889689
Conflicting classifications of pathogenicity
Cardiovascular phenotype, RASopathy, Cardiovascular phenotype
Health Risk
RS1303812580
Conflicting classifications of pathogenicity
RASopathy, CBL-related disorder, Central nervous system germ cell tumor
Health Risk
RS1365230067
Conflicting classifications of pathogenicity
RASopathy, Cardiovascular phenotype, RASopathy
Health Risk
RS1369884955
Conflicting classifications of pathogenicity
RASopathy, Cardiovascular phenotype, RASopathy
Health Risk
RS1377506801
Conflicting classifications of pathogenicity
RASopathy, CBL-related disorder, RASopathy
Health Risk
All Variants (136)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS1060500676 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, RASopathy |
| RS112330156 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Juvenile myelomonocytic leukemia |
| RS1188095865 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, CBL-related disorder |
| RS1188757026 | Health Risk | Conflicting classifications of pathogenicity | Cardiovascular phenotype, RASopathy, Cardiovascular phenotype |
| RS1193552867 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome and Noonan-related syndrome, RASopathy, Cardiovascular phenotype |
| RS1214485253 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS1229733932 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS1299889689 | Health Risk | Conflicting classifications of pathogenicity | Cardiovascular phenotype, RASopathy, Cardiovascular phenotype |
| RS1303812580 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Central nervous system germ cell tumor |
| RS1365230067 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS1369884955 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS1377506801 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, RASopathy |
| RS1422371091 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS142704935 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, Juvenile myelomonocytic leukemia |
| RS143034856 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Juvenile myelomonocytic leukemia |
| RS143132980 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype |
| RS143264567 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype |
| RS143840974 | Health Risk | Conflicting classifications of pathogenicity | Cardiovascular phenotype, RASopathy, Cardiovascular phenotype |
| RS143975631 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Juvenile myelomonocytic leukemia |
| RS144191570 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype |
| RS145155035 | Health Risk | Conflicting classifications of pathogenicity | CBL-related disorder, RASopathy, CBL-related disorder |
| RS1454595224 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Juvenile myelomonocytic leukemia |
| RS146250423 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Cardiovascular phenotype |
| RS146705974 | Health Risk | Conflicting classifications of pathogenicity | CBL-related disorder, RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS1473693007 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, RASopathy |
| RS149533467 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Noonan syndrome and Noonan-related syndrome |
| RS150811339 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS1592400852 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS187952822 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, CBL-related disorder |
| RS1949905314 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Cardiovascular phenotype |
| RS1949907918 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS1949969239 | Health Risk | Conflicting classifications of pathogenicity | Juvenile myelomonocytic leukemia, Cardiovascular phenotype, Juvenile myelomonocytic leukemia |
| RS1949969576 | Health Risk | Conflicting classifications of pathogenicity | Cardiovascular phenotype, Cardiovascular phenotype |
| RS1949996840 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, CBL-related disorder |
| RS1950067375 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome and Noonan-related syndrome, RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS199739868 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS199771745 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS199788586 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype |
| RS200220863 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS201620100 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS2135266156 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS2135303045 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS2135303902 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS2229073 | Health Risk | Conflicting classifications of pathogenicity | CBL-related disorder, RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS267606705 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, RASopathy |
| RS267606708 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Rhabdomyosarcoma, CBL-related disorder |
| RS369050822 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS369547447 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, CBL-related disorder, Juvenile myelomonocytic leukemia |
| RS370489946 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS371026706 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |